Skip to main content
SpringerLink
Log in

Transarterial Chemoembolization (TACE) for Inoperable Intrahepatic Cholangiocarcinoma

  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

The aim of this retrospective study was to determine the safety and efficacy of chemoembolization (TACE) as palliative treatment for patients with unresectable intrahepatic cholangiocarcinoma (CCA) and to compare the results with those in the literature. Fifteen patients with histology-proven CCA (5 men, 10 women) had received palliative treatment with TACE over a 6-year period. The treatment protocol comprised repeated TACE at a minimum of 8-week intervals. TACE was performed with a mixture of 10 ml Lipiodol and 10 mg mitomycin C injected into the tumor-supplying vessels. Follow-up investigations after 8–10 weeks comprised contrast-enhanced multislice spiral CT and laboratory control. Statistical evaluation included survival analysis using the Kaplan-Meier method. During the investigation period 58 TACEs (3.9 ± 3.8; 1–15) were performed in 15 patients. Mean tumor size was 10.8 ± 4.6 cm (range, 2.0–18.0 cm). Unifocal tumor disease was diagnosed in eight patients, and multifocal disease in seven. Mean survival was 21.1 months (95% CI, 9.4–32.5 months). At the end of the investigation period 3 patients are still alive, and 12 patients have died. The 1-, 2-, and 3-year survival rate was 51.3%, 27.5%, and 27.5% respectively. According to RECIST criteria interim best response to therapy was stable disease in 9 of 15 patients, a partial response in 1 of 15 patients, and tumor progression in 4 of 15 patients. No deaths and no acute liver failure occurred under TACE therapy. Major complications were observed in two patients, comprising anaphylactic shock owing to contrast medium administration in one and gastric ulceration due to lipiodol displacement in the second patient. These results demonstrate that TACE is a safe procedure with a moderate number of complications for patients suffering from inoperable CCA. According to recently published data on i.v. chemotherapy we suggest that TACE might be able to prolong survival in selected patients who would succumb under other palliative treatment modalities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Anderson CD, Pinson CW, Berlin J, et al. (2004) Diagnosis and treatment of cholangiocarcinoma. Oncologist 9(1):43–57

    Article  PubMed  Google Scholar 

  2. Khan S, Howard CT, Davidson BR, et al. (2005) Cholangiocarcinoma. Lancet 366:1303–1314

    Article  PubMed  Google Scholar 

  3. Olnes MJ, Erlich R (2004) A review and update on cholangiocarcinoma. Oncology 66(3):167–179

    Article  PubMed  Google Scholar 

  4. Farley DR, Weaver AL, Nagorney DM (1995) “Natural history” of unresected cholangiocarcinoma: patient outcome after noncurative intervention. Mayo Clin Proc 70(5):425–429

    Article  PubMed  CAS  Google Scholar 

  5. Heimbach JK, Gores GJ, Haddock MG, et al. (2004) Liver transplantation for unresectable perihilar cholangiocarcinoma. Semin Liver Dis 24(2):201–207

    Article  PubMed  Google Scholar 

  6. Llovet JM, Real MI, Montana X, et al. Barcelona Liver Cancer Group (2002) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359(9319):1734–1739

    Article  PubMed  Google Scholar 

  7. Lo CM, Ngan H, Tso WK, et al. (2002) Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35(5):1164–1171

    Article  PubMed  CAS  Google Scholar 

  8. Burger I, Hong K, Schulick R, et al. (2005) Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution. J Vasc Interv Radiol 16(3):353–361

    PubMed  Google Scholar 

  9. Huppert PE, Lauchart W, Duda S, et al. (2004) Chemoembolisation des hepatozellulären Karzinoms: Welche Faktoren bestimmen Therapieansprechen und Überleben? Fortschr Röntgenstr 176:375–385

    Article  CAS  Google Scholar 

  10. Therasse P (2002) Measuring the clinical response. What does it mean? Eur J Cancer 38(14):1817–1823

    Article  PubMed  CAS  Google Scholar 

  11. Sacks D, McClenny TE, Cardella JF, et al. (2003) Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol 14(9; Pt 2):S199–S202

    PubMed  Google Scholar 

  12. Ikeda M, Okusaka T, Ueno H, Morizane C, Furuse J, Ishii H (2005) A phase II trial of uracil-tegafur (UFT) in patients with advanced biliary tract carcinoma. Jpn J Clin Oncol 35(8):439–443

    Article  PubMed  Google Scholar 

  13. Okusaka T, Ishii H, Funakoshi A, et al. (2006) Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer. Cancer Chemother Pharmacol 57(5):647–653

    Article  PubMed  CAS  Google Scholar 

  14. Kornek GV, Schuell B, Laengle F, et al. (2004) Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial. Ann Oncol 15(3):478–483

    Article  PubMed  CAS  Google Scholar 

  15. Raderer M, Hejna MH, Valencak JB, et al. (1999) Two consecutive phase II studies of 5-fluorouracil/leucovorin/mitomycin C and of gemcitabine in patients with advanced biliary cancer. Oncology 56(3):177–180

    Article  PubMed  CAS  Google Scholar 

  16. Penz M, Kornek GV, Raderer M, et al. (2001) Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer. Ann Oncol 12(2):183–186

    Article  PubMed  CAS  Google Scholar 

  17. Marelli L, Stigliano R, Triantos C, et al. (2007) Transarterial therapy for hepatocellular carcinoma: Which technique is more effective? A systematic review of cohort and randomized studies Cardiovasc Intervent Radiol 30(1):6–25

    Google Scholar 

  18. Malhi H, Gores GJ (2006) Review article: the modern diagnosis and therapy of cholangiocarcinoma. Aliment Pharmacol Ther 23(9):1287–1296

    Article  PubMed  CAS  Google Scholar 

  19. Hejna M, Pruckmayer M, Raderer M (1998) The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature. Eur J Cancer 34(7):977–986

    Article  PubMed  CAS  Google Scholar 

  20. Todoroki T (2000) Chemotherapy for bile duct carcinoma in the light of adjuvant chemotherapy to surgery. Hepatogastroenterology 47(33):644–649

    PubMed  CAS  Google Scholar 

  21. Herber S, Schneider J, Brecher B, et al. (2005) TACE: therapy of the HCC before liver transplantation—experiences. Fortschr Röntgenstr 177(5):681–690 [in German]

    Article  CAS  Google Scholar 

  22. Otto G, Herber S, Heise M, et al. (2006) Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma. Liver Transpl 12(8):1260–1267

    Article  PubMed  Google Scholar 

  23. Kirchhoff T, Zender L, Merkesdal S, et al. (2005) Initial experience from a combination of systemic and regional chemotherapy in the treatment of patients with nonresectable cholangiocellular carcinoma in the liver. World J Gastroenterol 11(8):1091–1095

    PubMed  Google Scholar 

  24. Vogl TJ, Schwarz W, Eichler K, et al. (2006) Hepatic intraarterial chemotherapy with gemcitabine in patients with unresectable cholangiocarcinomas and liver metastases of pancreatic cancer: a clinical study on maximum tolerable dose and treatment efficacy. J Cancer Res Clin Oncol 132(11):745–755

    Article  PubMed  CAS  Google Scholar 

  25. Tanaka N, Yamakado K, Nakatsuka A, et al. (2002) Arterial chemoinfusion therapy through an implanted port system for patients with unresectable intrahepatic cholangiocarcinoma—initial experience. Eur J Radiol 41(1):42–48

    Article  PubMed  Google Scholar 

  26. Choi BI, Kim HC, Han JK, et al. (1992) Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: CT and pathologic findings. Radiology 182(3):709–713

    PubMed  CAS  Google Scholar 

  27. Eurvilaichit C (2004) Outcome of transcatheter oily chemoembolization in patients with hepatocellular carcinoma. Hepatogastroenterology 51(55):20–24

    PubMed  Google Scholar 

  28. Shimada M, Takenaka K, Kawahara N, et al. (1996) Chemosensitivity in primary liver cancers: evaluation of the correlation between chemosensitivity and clinicopathological factors. Hepatogastroenterology 43(11):1159–1164

    PubMed  CAS  Google Scholar 

  29. Lee GW, Kang JH, Kim HG, et al. (2006) Combination chemotherapy with gemcitabine and cisplatin as first-line treatment for immunohistochemically proven cholangiocarcinoma. Am J Clin Oncol 29(2):127–131

    Article  PubMed  CAS  Google Scholar 

  30. Asakura H, Ohtsuka M, Ito H, et al. (2005) Long-term survival after extended surgical resection of intrahepatic cholangiocarcinoma with extensive lymph node metastasis. Hepatogastroenterology 52(63):722–724

    PubMed  Google Scholar 

  31. Heron DE, Stein DE, Eschelman DJ, et al. (2003) Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome. Am J Clin Oncol 26(4):422–428

    Article  PubMed  Google Scholar 

  32. Park SH, Park YH, Lee JN, et al. (2006) Phase II study of epirubicin, cisplatin, and capecitabine for advanced biliary tract adenocarcinomas. Cancer 106(2):361–365

    Article  PubMed  CAS  Google Scholar 

  33. Knox JJ, Hedley D, Oza A, et al. (2005) Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial. J Clin Oncol 23(10):2332–2338

    Article  PubMed  CAS  Google Scholar 

  34. Papakostas P, Kouroussis C, Androulakis, et al. (2001) First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study. Eur J Cancer 37(15):1833–1838

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Diagnostic and Interventional Radiology, University of Mainz, Langenbeckstr. 1, 55131, Mainz, Germany

    S. Herber, J. Schneider, N. Manzl, I. Kummer, C. Düber & M. Pitton

  2. Department of Hepatobiliary Surgery, University of Mainz, Mainz, Germany

    G. Otto & J. Thies

  3. I. Medical Clinic, University of Mainz, Mainz, Germany

    S. Kanzler & A. Schuchmann

Authors
  1. S. Herber
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Otto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Schneider
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N. Manzl
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. I. Kummer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. Kanzler
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A. Schuchmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. J. Thies
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. C. Düber
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. M. Pitton
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Herber.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Herber, S., Otto, G., Schneider, J. et al. Transarterial Chemoembolization (TACE) for Inoperable Intrahepatic Cholangiocarcinoma. Cardiovasc Intervent Radiol 30, 1156–1165 (2007). https://doi.org/10.1007/s00270-007-9032-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-007-9032-7

Keywords

Search

Navigation